Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation

Eugene Shenderov, Michael A. Gorin, Seohyun Kim, Pamela T. Johnson, Mohamad E. Allaf, Alan W. Partin, Martin G. Pomper, Emmanuel S. Antonarakis, Kenneth J. Pienta, Steven P. Rowe

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Radiotracers targeting prostate-specific membrane antigen (PSMA), including [18F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [18F]DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0).

Original languageEnglish (US)
Pages (from-to)22-25
Number of pages4
JournalUrology Case Reports
Volume17
DOIs
StatePublished - Mar 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2017

Keywords

  • Carcinoid
  • PSMA
  • Prostate cancer

Fingerprint

Dive into the research topics of 'Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation'. Together they form a unique fingerprint.

Cite this